Skip to main content
logo
Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
42.32
+0.53 (1.27%)
At close: Aug 4, 2026, 4:00 PM EDT
41.55
-0.77 (-1.82%)
After-hours: Aug 4, 2026, 7:57 PM EDT

Definium Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
5,6181,32352315084582
Market Cap Growth
774.78%153.03%247.47%80.04%-85.65%-47.14%
Enterprise Value
5,285951.6270.8164.86-58.59448.68
Last Close Price
42.3213.396.963.662.2020.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
15.793.982.161.930.553.84
P/TBV Ratio
15.573.832.212.480.534.54

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/EBITDA Ratio
----0.93-
EV/EBIT Ratio
----0.88-
EV/FCF Ratio
----1.17-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.150.120.090.1800
Net Debt / Equity Ratio
-1.19-1.12-1.04-1.09-0.94-0.88
Net Debt / EBITDA Ratio
1.722.232.440.942.251.46
Net Debt / FCF Ratio
2.302.823.181.332.842.91
Quick Ratio
4.606.177.053.097.9412.83
Current Ratio
4.696.297.253.228.1613.18
Return on Equity (ROE)
-77.73%-64.06%-68.01%-83.59%-37.54%-81.78%
Return on Assets (ROA)
-45.96%-44.81%-48.71%-63.74%-39.72%-75.51%
Return on Invested Capital (ROIC)
----14072.86%-493.17%-1333.93%
Return on Capital Employed (ROCE)
-55.76%-52.24%-58.45%-76.81%-43.40%-80.87%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-19.43%-26.78%-79.94%-26.90%-12.71%-54.25%
Total Shareholder Return
-19.43%-26.78%-79.94%-26.90%-12.71%-54.25%